| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/22/2004 | US20040141946 Methods of treating neurological conditions with hematopoietic growth factors |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | CA2724305A1 Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
| 07/22/2004 | CA2512735A1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 07/22/2004 | CA2510584A1 Combination of reboxetine and a cyclooxygenase-2 inhibitor |
| 07/21/2004 | EP1439179A1 New oripavine derivatives and their uses as medicines |
| 07/21/2004 | EP1439176A1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 07/21/2004 | EP1439175A1 Pyrimidine compound and medicinal composition thereof |
| 07/21/2004 | EP1439174A1 4-imidazolin-2-one compounds |
| 07/21/2004 | EP1438963A1 Use of N2O for the treatment of postischemic cerebral cellular damages |
| 07/21/2004 | EP1438959A1 Controlled release oxycodone compositions |
| 07/21/2004 | EP1438956A1 Alpha-aminoamide derivatives useful as antimigraine agents |
| 07/21/2004 | EP1438942A1 An otorhinological drug delivery device |
| 07/21/2004 | EP1438583A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 07/21/2004 | EP1438405A1 Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene |
| 07/21/2004 | EP1438393A1 Differentiation of whole bone marrow |
| 07/21/2004 | EP1438392A2 Cell populations which co-express cd49c and cd90 |
| 07/21/2004 | EP1438329A1 Biologically active peptides and their use for repairing injured nerves |
| 07/21/2004 | EP1438320A1 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438311A2 A method of simultaneously treating sensory auditory gating deficit and associated psychosis in schizophrenia and bipolar disorder patients with mania |
| 07/21/2004 | EP1438310A1 Beta-carbolin derivatives as ptp-inhibitors |
| 07/21/2004 | EP1438309A1 Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
| 07/21/2004 | EP1438308A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists |
| 07/21/2004 | EP1438307A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 07/21/2004 | EP1438304A1 Novel substituted 4-phenyl-4- 1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 07/21/2004 | EP1438302A1 New sulfonamide derivatives as d3-receptor agonists |
| 07/21/2004 | EP1438296A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438289A1 Indole derivatives as cox ii inhibitors |
| 07/21/2004 | EP1438288A1 Substituted thioacetamides |
| 07/21/2004 | EP1438063A1 Modulation of physiological processes and agents useful for same |
| 07/21/2004 | EP1438061A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 07/21/2004 | EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438051A1 An enantiomerically pure diarylmethylpiperazine and methods of using same |
| 07/21/2004 | EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents |
| 07/21/2004 | EP1438036A2 Use of sulfonamide derivatives as pharmaceuticals compounds |
| 07/21/2004 | EP1438035A2 Pharmaceutical compositions for the treatment of urinary disorders |
| 07/21/2004 | EP1438020A2 Topical compositions and methods for treating pain |
| 07/21/2004 | EP1437961A2 Methods of suppressing microglial activation |
| 07/21/2004 | EP1351942B1 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient |
| 07/21/2004 | EP1254251A4 Neurosteroids as markers for alzheimer's disease |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP0958282B1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 07/21/2004 | EP0757685B1 Novel acyclic and cyclic amides as neurotransmitter release enhancers |
| 07/21/2004 | CN1514843A Somatostatin-dopamine chimeric analogs |
| 07/21/2004 | CN1514835A Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 07/21/2004 | CN1514825A New compounds useful in reflux disease |
| 07/21/2004 | CN1514736A Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 07/21/2004 | CN1514735A Ophthalmic composition comprising hyaluronic acid |
| 07/21/2004 | CN1514729A Sustained-release analgesic compounds |
| 07/21/2004 | CN1514728A Nicotine-containing film preparation |
| 07/21/2004 | CN1514723A Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 07/21/2004 | CN1514722A Controlled release dosage forms using acrylic polymer, and process for making |
| 07/21/2004 | CN1514721A Once-a-day oxycodone for mulations |
| 07/21/2004 | CN1514720A Self emulsifying lipid matrix (SELM) |
| 07/21/2004 | CN1513991A Recombination human alkaline fiber forming cell growth factor gene and its nonfusion expression product, production method and application |
| 07/21/2004 | CN1513844A New Carboxglic acid derivative, its preparation and application |
| 07/21/2004 | CN1513547A Stabilizing medicinal agent containing ciliary nerve nutritive factor analogue |
| 07/21/2004 | CN1513538A Chinese medicine for abstaining toxin drug and its preparation process |
| 07/21/2004 | CN1513519A Heart quieting and orifice opening capsule and its preparation |
| 07/21/2004 | CN1513516A Pure natural health care product for improving sleeping and its manufacturing method |
| 07/21/2004 | CN1513509A Formula of chinese herbal medicine composition for whole life abstaining drug habit |
| 07/21/2004 | CN1513506A Medicine for treating diabetes peripheral nerne affection |
| 07/21/2004 | CN1513505A Method for preparing qingkailing granules |
| 07/21/2004 | CN1513471A Injection of low molecular weight chondroitin sulfate and its prepn. method |
| 07/21/2004 | CN1513470A Health-care food with sobering function |
| 07/21/2004 | CN1513468A Compound medicine of sodium citicoline and disodium cytidine triphosphate |
| 07/21/2004 | CN1513443A Large volume injection of lysine glucose hydrochloride, and its prepn. method |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158290C Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/21/2004 | CN1158287C Benzothieno [3,2-c] pyridines as alpha 2-antagonists |
| 07/21/2004 | CN1158283C 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 07/21/2004 | CN1158260C Solid compound, preparation method therefor and use in medicine |
| 07/21/2004 | CN1158259C Potassium channel openers |
| 07/21/2004 | CN1158077C New application of benzene ring pelargonate hydrochloride |
| 07/20/2004 | US6765022 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 07/20/2004 | US6765014 1-Acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765010 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765008 Pyrrolopyrimidines as CRF antagonists |
| 07/20/2004 | US6765006 Antagonists of amino-3-hydroxy-5-methylisoxazole-4-propionic acid (ampa) ionotropic receptors; neurodegenerative, alzheimer's, and huntington's disease; amyotrophic lateral sclerosis; schizophrenia, excitatory amino acid deficiency |
| 07/20/2004 | US6765003 3-Arylsulfonyl-2 (substituted methyl) propanoic acid derivatives as matrix metalloproteinase inhibitors |
| 07/20/2004 | US6764824 Identifying non-sense mutation with codon tgg coding for tryptophan substituted with tag a non-sense codon at nucleotide 825 in exon 2 of synaptogyrin 1 gene of chromosome 22q11-13, detecting pre-disposition to schizophrenia |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | CA2286733C Reverse-turn mimetics and methods relating thereto |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/15/2004 | WO2004058974A1 A method of drug screening to select agonists or antagonists of g protein coupled receptors (gpcr). |
| 07/15/2004 | WO2004058773A1 Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms |
| 07/15/2004 | WO2004058767A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 07/15/2004 | WO2004058764A1 4-phenyl-pyrimido [4,5-b] indole derivatives |